Exhibit 21.1
Subsidiaries
Name of Subsidiary | Jurisdiction of Incorporation or Organization | Percentage of Ownership by the Registrant | ||||||||||||
B10 Health Technologies Private Limited | India | 100 | % | |||||||||||
BeiGene 101 | Cayman Islands | 100 | % | |||||||||||
BeiGene AUS Pty Ltd | Australia | 100 | % | |||||||||||
BeiGene Austria GmbH | Austria | 100 | % | |||||||||||
BeiGene (Beijing) Co., Ltd. | People’s Republic of China | 100 | % | |||||||||||
BeiGene Biologics Co., Ltd. | People’s Republic of China | 100 | % | |||||||||||
BeiGene Brasil Ltda. | Brazil | 100 | % | |||||||||||
BeiGene (Canada) ULC | Canada | 100 | % | |||||||||||
BeiGene Colombia S.A.S. | Colombia | 100 | % | |||||||||||
BeiGene ESP, S.L. | Spain | 100 | % | |||||||||||
BeiGene France Sarl | France | 100 | % | |||||||||||
BeiGene Germany GmbH | Germany | 100 | % | |||||||||||
BeiGene Guangzhou Biologics Manufacturing Co., Ltd. | People’s Republic of China | 100 | % | |||||||||||
BeiGene (Guangzhou) Innovation Technology Co., Ltd. | People’s Republic of China | 100 | % | |||||||||||
BeiGene (Hong Kong) Co., Limited | Hong Kong | 100 | % | |||||||||||
BeiGene Hopewell Urban Renewal, LLC | New Jersey, United States | 100 | % | |||||||||||
BeiGene International GmbH | Switzerland | 100 | % | |||||||||||
BeiGene Ireland Limited | Republic of Ireland | 100 | % | |||||||||||
BeiGene (Italy) S.r.l. | Italy | 100 | % | |||||||||||
BeiGene Japan GK | Japan | 100 | % | |||||||||||
BeiGene Korea Y.H. | South Korea | 100 | % | |||||||||||
BeiGene Netherlands B.V. | Netherlands | 100 | % | |||||||||||
BeiGene NZ Unlimited | New Zealand | 100 | % | |||||||||||
BeiGene Pharmaceuticals GmbH | Switzerland | 100 | % | |||||||||||
BeiGene Pharmaceuticals (Guangzhou) Co., Ltd. | People’s Republic of China | 100 | % | |||||||||||
BeiGene Pharmaceuticals Israel Ltd. | Israel | 100 | % | |||||||||||
BeiGene Pharmaceutical (Shanghai) Co., Ltd. | People’s Republic of China | 100 | % | |||||||||||
BeiGene Poland sp. z o.o. | Poland | 100 | % | |||||||||||
BeiGene Shanghai | Cayman Islands | 100 | % | |||||||||||
BeiGene Shanghai 101 | Cayman Islands | 100 | % | |||||||||||
BeiGene (Shanghai) Co., Ltd. | People’s Republic of China | 100 | % | |||||||||||
BeiGene (Shanghai) Management Consulting Co., Ltd. | People’s Republic of China | 100 | % | |||||||||||
BeiGene (Shanghai) Research & Development Co., Ltd. | People’s Republic of China | 100 | % | |||||||||||
BeiGene Singapore Pte. Ltd. | Singapore | 100 | % | |||||||||||
BeiGene South Africa Pty Ltd. | South Africa | 100 | % | |||||||||||
BeiGene (Suzhou) Co., Ltd. | People’s Republic of China | 100 | % | |||||||||||
BeiGene Sweden AB | Sweden | 100 | % | |||||||||||
BeiGene Switzerland GmbH | Switzerland | 100 | % | |||||||||||
BeiGene (Taiwan) Limited | Taiwan | 100 | % | |||||||||||
BeiGene (Thailand) Ltd. | Thailand | 100 | % | |||||||||||
BeiGene Turkey Medical Products Trade Limited Company | Turkey | 100 | % | |||||||||||
BeiGene UK, Ltd. | United Kingdom | 100 | % | |||||||||||
BeiGene United Kingdom, Ltd. | United Kingdom | 100 | % | |||||||||||
BeiGene USA, Inc. | Delaware, United States | 100 | % |
Exhibit 21.1
BeiGene US Holdings, LLC | Delaware, United States | 100 | % | |||||||||||
BeiGene US Manufacturing Co., Inc. | Delaware, United States | 100 | % | |||||||||||
Beijing Innerway Bio-tech Co., Ltd. | People’s Republic of China | 100 | % | |||||||||||
Newco 101 | Cayman Islands | 100 | % | |||||||||||
Pi Health Brasil Consultoria Ltda. | Brazil | 100 | % | |||||||||||
Pi Health Hong Kong Limited | Hong Kong | 100 | % | |||||||||||
Pi Health, Ltd. | Cayman Islands | 100 | % | |||||||||||
Pi Health USA, LLC | Delaware, United States | 100 | % | |||||||||||
SuGene Pharmaceuticals (Suzhou) Co., Ltd. | People’s Republic of China | 100 | % |